Eulerpool Data & Analytics INHIBIKASE THERAPEUTICS, INC. WILMINGTON, US-DE
Nom
INHIBIKASE THERAPEUTICS, INC.
Adresse
INHIBIKASE THERAPEUTICS, INC.
c/o PHS CORPORATE SERVICES
INC.
1313 N MARKET ST STE 5100
19801 WILMINGTON
Siège
3350 Riverwood Parkway Southeast; Suite 1900, 30339 Atlanta
Legal Entity Identifier (LEI)
549300066CFEWOA17F12
Legal Operating Unit (LOU)
5299000J2N45DDNE4Y28
Numéro d'enregistrement
4832244
Forme d'entreprise
XTIQ
Catégorie d'entreprise
Général
Statut
Émis
Statut de validation
Entièrement Confirmé
Dernière mise à jour
29/08/2023
Prochaine renouvellement
29/08/2024
Eulerpool API INHIBIKASE THERAPEUTICS, INC. Chiffre d’affaires, bénéfice, bilan, brevets, employés et plus WILMINGTON, US-DE
{
"lei": "549300066CFEWOA17F12",
"legal_jurisdiction": "US-DE",
"legal_name": "INHIBIKASE THERAPEUTICS, INC.",
"entity_category": "GENERAL",
"entity_legal_form_code": "XTIQ",
"legal_first_address_line": "c/o PHS CORPORATE SERVICES, INC., 1313 N MARKET ST STE 5100",
"legal_additional_address_line": "",
"legal_city": "WILMINGTON",
"legal_postal_code": "19801",
"headquarters_first_address_line": "3350 Riverwood Parkway Southeast; Suite 1900",
"headquarters_additional_address_line": "",
"headquarters_city": "Atlanta",
"headquarters_postal_code": "30339",
"registration_authority_entity_id": "4832244",
"next_renewal_date": "2024-08-29T13:00:07.000Z",
"last_update_date": "2023-08-29T13:00:07.000Z",
"managing_lou": "5299000J2N45DDNE4Y28",
"registration_status": "ISSUED",
"validation_sources": "FULLY_CORROBORATED",
"reporting_exception": "",
"slug": "INHIBIKASE THERAPEUTICS, INC.,WILMINGTON,4832244"
}Autres entreprises dans la même juridiction